Cgm Dexcom denied due to quantity / dose limits by Aetna?
Quantity-limit denials usually flip when the appeal documents the clinically appropriate dose for the patient's weight, kidney function, or escalation schedule, citing the FDA label or specialty-society guideline.
US health-plan appeal rights
Cite: Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules
Most US health plans are required by federal law to give you both an internal appeal (where the insurer reconsiders) and an external review (where an independent reviewer decides). The exact timelines and processes depend on what kind of plan you have — marketplace / employer group, self-funded, Medicare Advantage, or Medicaid MCO — but in every case there's a window after the denial during which you have the right to fight it.
What Aetna typically requires
Aetna's specific coverage criteria for cgm dexcom are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.
The Aetna angle on Cgm Dexcom
## Why Aetna Denied Your Dexcom CGM Under Quantity Limits
A quantity-limit denial means Aetna has approved Dexcom CGM coverage for you — but at a lower supply quantity than your prescriber ordered. For CGM supplies (sensors, transmitters, receivers), quantity limits are common and reflect Aetna's default coverage parameters for your plan. When your prescriber orders a quantity above the plan default, the excess is denied as exceeding the allowed limit.
This denial is appealable when your clinical situation requires the higher quantity. Common reasons include accelerated sensor wear due to physical activity, higher body perspiration, or more frequent calibration needs; your prescriber's clinical judgment that closer monitoring intervals are medically necessary; or documented inadequacy of the standard quantity for your glucose management goals.
## Your Federal Appeal Rights
- Internal appeal: File within the deadline on your denial notice. Aetna must decide within 30 days (standard) or 72 hours (urgent/expedited).
- External review (ACA §2719 / ERISA §503): After a final internal denial, you may request independent external review — typically within approximately four months. The IRO decision is binding.
- Quantity-limit exception: Simultaneously request a quantity-limit exception through your prescriber. This is a separate administrative pathway from the appeal.
## Documentation to Gather
1. Prescriber letter explaining clinical need for higher quantity: Your physician should explain in specific clinical terms why the standard quantity is insufficient for your management — without citing specific numeric thresholds, the letter should reference your individual clinical factors (activity level, monitoring frequency, skin tolerance, etc.). 2. Usage history: Any records showing how quickly you have used prior supplies, device malfunction or premature failure documentation, or pharmacy dispensing history. 3. Diagnosis and regimen documentation: Chart notes confirming diagnosis, insulin regimen, and monitoring goals. 4. Clinical severity factors: Notes documenting any relevant factors that increase your monitoring needs compared to an average patient. 5. Aetna's quantity-limit criteria: Obtain Aetna's published quantity-limit parameters for CGM supplies and identify whether an exception process exists.
## Criteria-Mapping Structure
Obtain Aetna's CGM supply quantity-limit policy. Identify whether the policy has a medical exception pathway. If so, list each exception criterion and respond to it with a specific chart reference. Your prescriber's letter is the cornerstone — it should address each factor the policy identifies as a basis for approving higher quantities.
Quantity-limit appeals succeed when there is a clear, individualized clinical explanation for why the default quantity is not medically sufficient. Generic requests are less effective than a letter tied to your specific chart findings.
Next steps
- Find the date on the denial letter — your appeal window starts there.
- Read your plan's Summary of Benefits and Coverage (SBC) for the specific deadlines.
- Request the insurer's claim file in writing — they must provide it.
- Submit your appeal in writing with new clinical evidence and a physician statement.
Get the letter drafted
DenialHelp drafts your appeal in 5 minutes — $40 list price, $30 for your first letter (use code SEO25). We cite the federal regs and the specific clinical evidence your plan responds to. Your physician signs and sends.
Start my appeal — $30 with code SEO25 →